人福医药：产品取得注册证

每日经济新闻07-08

每经AI快讯，人福医药（SH 600079，收盘价：16.6元）7月8日晚间发布公告称，人福医药集团股份公司控股子公司武汉人福利康药业有限公司近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。产品名称为“帕拉米韦注射液”。2023年1至12月份，人福医药的营业收入构成为：医药占比53.05%，医药批发及相关业占比46.05%。截至发稿，人福医药市值为271亿元。道达号（...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2449977511?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-08 18:56","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2449977511","market":"sh","top_or_hot":-1,"title":"人福医药：产品取得注册证","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，人福医药（SH 600079，收盘价：16.6元）7月8日晚间发布公告称，人福医药集团股份公司控股子公司武汉人福利康药业有限公司近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。产品名称为“帕拉米韦注射液”。2023年1至12月份，人福医药的营业收入构成为：医药占比53.05%，医药批发及相关业占比46.05%。截至发稿，人福医药市值为271亿元。道达号（...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>人福医药：产品取得注册证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n人福医药：产品取得注册证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-08 18:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，人福医药（SH 600079，收盘价：16.6元）7月8日晚间发布公告称，人福医药集团股份公司控股子公司武汉人福利康药业有限公司近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。产品名称为“帕拉米韦注射液”。2023年1至12月份，人福医药的营业收入构成为：医药占比53.05%，医药批发及相关业占比46.05%。截至发稿，人福医药市值为271亿元。道达号（...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b","article_id":"2449977511","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2449977511","pubTimestamp":1720436207,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"每经AI快讯，人福医药 7月8日晚间发布公告称，人福医药集团股份公司控股子公司武汉人福利康药业有限公司近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。产品名称为“帕拉米韦注射液”。2023年1至12月份，人福医药的营业收入构成为：医药占比53.05%，医药批发及相关业占比46.05%。截至发稿，人福医药市值为271亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600079":"人福医药","BK0188":"融资融券","BK0028":"国家队","BK0070":"员工持股","BK0096":"民营医院","BK0012":"证金概念","BK0239":"医药制造","BK0185":"二线龙头"},"translate_title":"Renfu Pharmaceutical: Product obtained registration certificate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600079":1},"content_text":"每经AI快讯，人福医药（SH 600079，收盘价：16.6元）7月8日晚间发布公告称，人福医药集团股份公司控股子公司武汉人福利康药业有限公司近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。产品名称为“帕拉米韦注射液”。2023年1至12月份，人福医药的营业收入构成为：医药占比53.05%，医药批发及相关业占比46.05%。截至发稿，人福医药市值为271亿元。道达号（daoda1997）“个股趋势”提醒：1. 人福医药近30日内北向资金持股量减少598.97万股，占流通股比例减少0.38%；2. 近30日内无机构对人福医药进行调研。每经头条（nbdtoutiao）——海航濒临“1元”面值退市生死线！方大系，出手了！但部分股民却不满了(记者 陈鹏程)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2449977511"}